Suppr超能文献

医生改良的胸降主动脉近端腔内修复术与杂交修复术的比较

Physician-Modified TEVAR versus Hybrid Repair of the Proximal Descending Thoracic Aorta.

作者信息

Yordanov Miroslav Dimitrov, Oberhuber Alexander, Ibrahim Abdulhakim

机构信息

Department of Vascular and Endovascular Surgery, University Hospital Muenster, 48149 Muenster, Germany.

出版信息

J Clin Med. 2022 Jun 16;11(12):3455. doi: 10.3390/jcm11123455.

Abstract

There are different surgical options for the treatment of proximal lesions of the descending thoracic aorta. The aim of this study was to compare the outcome of physician-modified TEVAR (pmTEVAR) vs. hybrid repair of the thoracic aorta in terms of TEVAR with carotid-subclavian bypass (hdTEVAR). This was a single-centre, retrospective comparative study of all patients who underwent pmTEVAR and hybrid repair of the proximal descending aorta from January 2018 to June 2021. Primary outcomes were technical success, 30-day mortality, perioperative stroke, 30-day reinterventions and supraaortic access related complications. Secondary outcomes were patient survival, late complications, late reinterventions, and bypass/bridging stent patency. A total of 181 patients underwent TEVAR within the period of 42 months. In our study, only patients with proximal landing in zone 2 ( = 39) were included. A total of 5 of 15 pmTEVAR and 8 of 24 hybrid repair operations (33% vs. 33%, respectively) were performed due to aneurysms. Among the rest of the patients, 10 of 15 pmTEVAR and 16 of 24 hybrid operations (67% vs. 67%) were performed due to aortic dissection. Technical success was achieved in 100% of the patients. No significant difference in terms of postoperative complications could be detected in the early and midterm follow up period. The 30-day mortality was 12.5% in the hybrid repair group ( = 3) vs. 6.66% ( = 1) in the pmTEVAR group ( = 0.498). These patients underwent the operation in an emergency setting. No patient died after an elective operation. The causes of early mortality were major stroke ( = 2), haemorrhagic shock ( = 1) in the hybrid group and progredient spinal cord ischemia with tetraplegia and acute respiratory insufficiency ( = 1) in the pmTEVAR group. In conclusion, both therapies are robust techniques, with comparable patency rate and perioperative complications. pmTEVAR appears to be advantageous in terms of operation time and tendency to lower mortality rates.

摘要

对于胸降主动脉近端病变的治疗有不同的手术选择。本研究的目的是比较医生改良的胸主动脉腔内修复术(pmTEVAR)与采用颈动脉-锁骨下动脉旁路移植术的胸主动脉杂交修复术(hdTEVAR)的治疗效果。这是一项对2018年1月至2021年6月期间所有接受pmTEVAR和近端降主动脉杂交修复术患者的单中心回顾性比较研究。主要结局指标为技术成功率、30天死亡率、围手术期卒中、30天再次干预以及与主动脉弓上血管入路相关的并发症。次要结局指标为患者生存率、晚期并发症、晚期再次干预以及旁路/桥接支架通畅情况。在42个月期间共有181例患者接受了胸主动脉腔内修复术。在我们的研究中,仅纳入了近端锚定区位于2区的患者(n = 39)。15例pmTEVAR手术中的5例以及24例杂交修复手术中的8例(分别为33%和33%)是由于动脉瘤而进行的。在其余患者中,15例pmTEVAR手术中的10例以及24例杂交手术中的16例(分别为67%和67%)是由于主动脉夹层而进行的。所有患者均实现了技术成功。在早期和中期随访期间,未发现术后并发症方面存在显著差异。杂交修复组的30天死亡率为12.5%(n = 3),而pmTEVAR组为6.66%(n = 1)(P = 0.498)。这些患者均在急诊情况下接受了手术。择期手术后无患者死亡。早期死亡原因在杂交组为严重卒中(n = 2)、失血性休克(n = 1),在pmTEVAR组为进行性脊髓缺血伴四肢瘫和急性呼吸功能不全(n = 1)。总之,两种治疗方法都是可靠的技术,通畅率和围手术期并发症相当。pmTEVAR在手术时间和降低死亡率趋势方面似乎更具优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c879/9225072/e3c63208a7cf/jcm-11-03455-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验